Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. - Wikidata - wikimedia - TriplyDB

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

http://www.wikidata.org/entity/Q55469941

about

YKL-40 tissue expression and plasma levels in patients with ovarian cancer Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics Recent advances in the molecular understanding of glioblastoma A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy A drosophila model for EGFR-Ras and PI3K-dependent human glioma Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era.Immunohistochemical assessment of protein phosphorylation state: the dream and the reality Network-constrained regularization and variable selection for analysis of genomic data.Predictive and prognostic markers in neuro-oncology.Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.Resveratrol represses YKL-40 expression in human glioma U87 cells.Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.High expression of mTOR is associated with radiation resistance in cervical cancer Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients The mTOR signaling pathway as a treatment target for intracranial neoplasms Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency.Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma.Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.The challenges and the promise of molecular targeted therapy in malignant gliomas.Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.Drosophila melanogaster as a model system for human brain cancers.Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells.The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas.Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas.High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma.Is YKL-40 a new therapeutic target in cancer?Gene Encoding Chitinase 3-Like 1 Protein (CHI3L1) is a Putative Oncogene Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung.Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas

P2860

Q21260376-C41BFAD5-9315-4EE7-96D6-34ECAD3A37C4 Q24295370-4975D25A-80CF-46A8-A41C-265FF0B1AEAB Q24322118-7565C4FC-7F08-45D5-8C80-94961BF5609D Q24618080-204B8785-FDF1-425A-AEFF-1B78C033E465 Q24632928-839AC0BE-85BC-42CD-9ED1-DC6E1D88A7FB Q26849503-095483E9-5291-4820-B1ED-113BBD198CB5 Q27312887-2FE18654-573D-410B-91A2-FC99FDFA5D2F Q27851755-084DFDD0-EFA2-4142-BBBE-997E78E6F970 Q30441231-F31D5D46-3974-4E25-96D6-4CDE3A5CF608 Q31148172-9C4E9B14-1DC3-4A3A-B377-61046C8CB963 Q33311133-2810FF8E-E5B2-4B73-AD8A-97011F8FFE4E Q33407127-EA46F766-2983-4C2B-B9D3-F1AA48056239 Q33719157-4E4E1D93-D70B-4C6C-9769-7BA17AE2419E Q33732189-04BE51D5-5A1D-4F44-B8BD-54806850CDDF Q33747609-717AE878-BA65-419E-82CE-284EF4F9177D Q33818584-74D280D0-85DC-4347-8941-3DCCB959CA2B Q33900952-D4DD9B97-50F3-4C3C-A556-FC9926770F86 Q33925544-4A655865-BD38-4F44-845E-ED113ADAD517 Q34105105-424D2D7C-85AF-4EA9-A10C-17499A482E4B Q34167071-F67C9FAB-86D3-494B-AE42-61DDBD718215 Q34234351-AE6554FC-1A83-4F05-914C-CA2A443F550A Q34250109-DB84ED43-B31D-4146-935C-2A2C205C705B Q34729001-05DAE014-9D18-4F0A-903F-DE4474DD37E1 Q34886859-A2177394-A5BE-4E1E-8375-98CFDEF43D90 Q34939141-930C6CA5-DFD2-470D-B93D-FBD3B5650E7E Q35008709-C5A7736A-F17D-4FA2-8624-E31AD50D530D Q35013574-40EB3997-908C-4BBC-A702-C3B5E9E3F1A4 Q35214534-0C92F1BA-8AC8-411D-ADD8-C132DD73F465 Q35242525-042BC154-FCCC-45F2-A40B-70335D615D6C Q35566228-8FFF9636-005E-4174-8147-9540C3144800 Q35841656-ABC7EDA2-00AD-497C-9E67-0A282C34759F Q35864082-E01D2C3E-8DC5-4DA8-8342-1830857472B4 Q36428239-6073D630-7B51-4526-AA37-31319E0A6EE0 Q36485266-B45B9CD2-290A-4BB2-AA5F-C9D2B1FDAB65 Q36500396-D39E32EB-D03B-4A94-9E06-1329689CE0CA Q36544089-9724C7C1-A3E0-4B2C-A50B-CA8D6B1BD27A Q36709555-84F2F22B-D127-40C5-B2BB-5BCA76600BA0 Q36735677-1A431032-0258-4CF3-A3D2-AFF8B0490B71 Q37038176-E4B3A612-ED88-4936-A581-B97DFE4EDFB5 Q37174303-96A8CFBC-B4B9-4EF5-A60C-D59B03CA55BE

P2860

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

http://www.wikidata.org/entity/Q55469941

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Prognostic associations of act ...... Akt pathways in glioblastoma.

@en

Prognostic associations of act ...... Akt pathways in glioblastoma.

@nl

type

label

Prognostic associations of act ...... Akt pathways in glioblastoma.

@en

Prognostic associations of act ...... Akt pathways in glioblastoma.

@nl

prefLabel

Prognostic associations of act ...... Akt pathways in glioblastoma.

@en

Prognostic associations of act ...... Akt pathways in glioblastoma.

@nl

P1433

Q55469941-57F2D37D-4354-4903-9E91-429C1FB780BF

P1476

Q55469941-DC88DDCA-8CC1-45CF-B9D4-34C705FDE32F

P2093

Q55469941-229359DE-CBB9-4CB3-9041-FB58C99D32AE

Q55469941-2510AB46-0076-41C6-AEC9-8B43090C8E35

Q55469941-2B731638-AC34-4E17-B962-C43CAFB40977

Q55469941-31C742D1-251D-4B60-B165-20C1B9C5DA23

Q55469941-35861B91-B10B-447B-B1A2-5371638EEEEA

Q55469941-38FAE24C-34D4-43BB-B688-A0EC26EFA75E

Q55469941-3AD6C0C9-F5DE-45E2-84EA-453436457E66

Q55469941-4190621A-913D-47DA-A41B-D1CC071E580A

Q55469941-4F5E4F14-8204-4A27-8300-2C19FF19A4EE

Q55469941-99D46B7D-1F9A-47F6-BF01-151D6DCA9BC0

P304

Q55469941-59B38749-69D8-4672-B6A6-13FBAB24DEE5

P31

Q55469941-23743029-FEB7-42BE-AA18-F7C2DA710600

P356

Q55469941-D20A4766-C2E3-4149-9E7A-2E31A6AE0FAF

P407

Q55469941-BEB42FAA-28DB-4150-9B08-B27CB4D5DBF1

P433

Q55469941-9C53EC84-E0BC-42BE-9194-A3EB3435F5D1

P478

Q55469941-64B7C989-A707-42DC-B747-42DA1A737E86

P50

Q55469941-89F96C99-5A48-4166-96A0-D770123757A7

P577

Q55469941-86D8D1F6-5063-4323-8D42-9DE5AA583CAA

P5875

Q55469941-F7C52469-D751-4E88-8972-9AC5D83779A3

P698

Q55469941-C69D55C6-D53D-4ED6-8D7D-9DC7581B2508

P356

1078-0432.CCR-05-2202

P1433

Clinical Cancer Research

P1476

Prognostic associations of act ...... Akt pathways in glioblastoma.

@en

P2093

Amy B Heimberger

http://www.w3.org/2001/XMLSchema#string

Christopher E Pelloski

http://www.w3.org/2001/XMLSchema#string

Dima Suki

http://www.w3.org/2001/XMLSchema#string

E Lin

http://www.w3.org/2001/XMLSchema#string

Fredrick G Barker

http://www.w3.org/2001/XMLSchema#string

Howard Colman

http://www.w3.org/2001/XMLSchema#string

Juinn-Lin Liu

http://www.w3.org/2001/XMLSchema#string

Kenneth D Aldape

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Michael Prados

http://www.w3.org/2001/XMLSchema#string

P304

3935-3941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-2202

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6965654

http://www.w3.org/2001/XMLSchema#string

P698

16818690

http://www.w3.org/2001/XMLSchema#string